top of page

Potential Sanfilippo Treatment, SLS-005, Advances as Orphan Drug in EU

Updated: Jul 24, 2020

The Committee for Orphan Medicinal Products, a branch of the European Medicines Agency (EMA), favours than designating SLS-005 (trehalose) an orphan drug as a potential treatment for Sanfilippo syndrome, Seelos Therapeutics, its developer, announced.

Want to read more?

Subscribe to ausdis.au to keep reading this exclusive post.

5 views0 comments

Comments

Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page